Marginal zone lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up von Zucca, E., Arcaini, L., Buske, C., Johnson, P.W., Ponzoni, M., Raderer, M., Ricardi, U., Salar, A., Stamatopoulos, K., Thieblemont, C., Wotherspoon, A., Ladetto, M.

Volltext

The anti-lymphoma activity of antiviral therapy in HCV-associated B-cell non-Hodgkin lymphomas: a meta-analysis von Peveling-Oberhag, J., Arcaini, L., Bankov, K., Zeuzem, S., Herrmann, E.

Volltext

ESMO Consensus conferences: guidelines on malignant lymphoma. part 2: marginal zone lymphoma, mantle cell lymphoma, peripheral T-cell lymphoma von Dreyling, M., Thieblemont, C., Gallamini, A., Arcaini, L., Campo, E., Hermine, O., Kluin-Nelemans, J.C., Ladetto, M., Le Gouill, S., Iannitto, E., Pileri, S., Rodriguez, J., Schmitz, N., Wotherspoon, A., Zinzani, P., Zucca, E.

Volltext

From hepatitis C virus infection to B-cell lymphoma von Couronné, L., Bachy, E., Roulland, S., Nadel, B., Davi, F., Armand, M., Canioni, D., Michot, J.M., Visco, C., Arcaini, L., Besson, C., Hermine, O.

Volltext

Antiviral treatment in patients with indolent B-cell lymphomas associated with HCV infection: a study of the Fondazione Italiana Linfomi von Arcaini, L., Vallisa, D., Rattotti, S., Ferretti, V.V., Ferreri, A.J.M., Bernuzzi, P., Merli, M., Varettoni, M., Chiappella, A., Ambrosetti, A., Tucci, A., Rusconi, C., Visco, C., Spina, M., Cabras, G., Luminari, S., Tucci, M., Musto, P., Ladetto, M., Merli, F., Stelitano, C., d'Arco, A., Rigacci, L., Levis, A., Rossi, D., Spedini, P., Mancuso, S., Marino, D., Bruno, R., Baldini, L., Pulsoni, A.

Volltext

A prospective study of 338 patients with polycythemia vera: the impact of JAK2 (V617F) allele burden and leukocytosis on fibrotic or leukemic disease transformation and vascular co... von Passamonti, F, Rumi, E, Pietra, D, Elena, C, Boveri, E, Arcaini, L, Roncoroni, E, Astori, C, Merli, M, Boggi, S, Pascutto, C, Lazzarino, M, Cazzola, M

Volltext

The Krüppel-like factor 2 transcription factor gene is recurrently mutated in splenic marginal zone lymphoma von Piva, R, Deaglio, S, Famà, R, Buonincontri, R, Scarfò, I, Bruscaggin, A, Mereu, E, Serra, S, Spina, V, Brusa, D, Garaffo, G, Monti, S, Dal Bo, M, Marasca, R, Arcaini, L, Neri, A, Gattei, V, Paulli, M, Tiacci, E, Bertoni, F, Pileri, S A, Foà, R, Inghirami, G, Gaidano, G, Rossi, D

Volltext

Dysregulation of global microRNA expression in splenic marginal zone lymphoma and influence of chronic hepatitis C virus infection von Peveling-Oberhag, J, Crisman, G, Schmidt, A, Döring, C, Lucioni, M, Arcaini, L, Rattotti, S, Hartmann, S, Piiper, A, Hofmann, W-P, Paulli, M, Küppers, R, Zeuzem, S, Hansmann, M-L

Volltext

The use of FDG-PET in the initial staging of 142 patients with follicular lymphoma: a retrospective study from the FOLL05 randomized trial of the Fondazione Italiana Linfomi von Luminari, S., Biasoli, I., Arcaini, L., Versari, A., Rusconi, C., Merli, F., Spina, M., Ferreri, A.J.M., Zinzani, P.L., Gallamini, A., Mastronardi, S., Boccomini, C., Gaidano, G., D'Arco, A.M., Di Raimondo, F., Carella, A.M., Santoro, A., Musto, P., Federico, M.

Volltext

Prognostic factors for thrombosis, myelofibrosis, and leukemia in essential thrombocythemia: a study of 605 patients von Passamonti, Francesco, Rumi, Elisa, Arcaini, Luca, Boveri, Emanuela, Elena, Chiara, Pietra, Daniela, Boggi, Sabrina, Astori, Cesare, Bernasconi, Paolo, Varettoni, Marzia, Brusamolino, Ercole, Pascutto, Cristiana, Lazzarino, Mario

Volltext

Exposure to obinutuzumab does not affect outcomes of SARS‐CoV‐2 infection in vaccinated patients with newly diagnosed advanced‐stage follicular lymphoma von Pinto, A., Caltagirone, M., Battista, M., Gazzoli, G. C., Patti, C., Pennese, E., De Lorenzo, S., Pavone, V., Merli, M., Chiarenza, A., Gorgone, A. G., Piazza, F., Puccini, B., Noto, A., Arcaini, L., De Filippi, R., Zinzani, P. L., Ferreri, A. J. M., Ladetto, M., Ferrari, S., Gritti, G.

Volltext

Corrigendum to “Marginal zone lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up”: [Annals of Oncology 31 (2020) 17–29] von Zucca, E., Arcaini, L., Buske, C., Johnson, P.W., Ponzoni, M., Raderer, M., Ricardi, U., Salar, A., Stamatopoulos, K., Thieblemont, C., Wotherspoon, A., Ladetto, M.

Volltext

Splenic marginal zone lymphoma: a prognostic model for clinical use von Arcaini, Luca, Lazzarino, Mario, Colombo, Nora, Burcheri, Sara, Boveri, Emanuela, Paulli, Marco, Morra, Enrica, Gambacorta, Marcello, Cortelazzo, Sergio, Tucci, Alessandra, Ungari, Marco, Ambrosetti, Achille, Menestrina, Fabio, Orsucci, Lorella, Novero, Domenico, Pulsoni, Alessandro, Frezzato, Maurizio, Gaidano, Gianluca, Vallisa, Daniele, Minardi, Viviana, Tripodo, Claudio, Callea, Vincenzo, Baldini, Luca, Merli, Francesco, Federico, Massimo, Franco, Vito, Iannitto, Emilio

Volltext

Venetoclax and azacytidine combination is an effective bridge to transplant strategy in relapsed/refractory acute myeloid leukemia patients von Zappasodi, P., Brociner, M., Merati, G., Nizzoli, M. E., Roncoroni, E., Boveri, E., Castagnola, C., Arcaini, L.

Volltext

Relation between JAK2 (V617F) mutation status, granulocyte activation, and constitutive mobilization of CD34+ cells into peripheral blood in myeloproliferative disorders von Passamonti, Francesco, Rumi, Elisa, Pietra, Daniela, Porta, Matteo G. Della, Boveri, Emanuela, Pascutto, Cristiana, Vanelli, Laura, Arcaini, Luca, Burcheri, Sara, Malcovati, Luca, Lazzarino, Mario, Cazzola, Mario

Volltext

Prevalence of HCV infection in nongastric marginal zone B-cell lymphoma of MALT von Arcaini, L., Burcheri, S., Rossi, A., Paulli, M., Bruno, R., Passamonti, F., Brusamolino, E., Molteni, A., Pulsoni, A., Cox, M.C., Orsucci, L., Fabbri, A., Frezzato, M., Voso, M.T., Zaja, F., Montanari, F., Merli, M., Pascutto, C., Morra, E., Cortelazzo, S., Lazzarino, M.

Volltext

MYC ALTERATIONS IN HIV‐ASSOCIATED B CELL LYMPHOMAS: RESULTS OF “EUROMYC” STUDY (A EUROPEAN RETROSPECTIVE STUDY) von Pagani, C., Rusconi, C., Pria, A. Dalla, Ravano, E., Schommers, P., Bastos‐Oreiro, M., Verga, L., Gini, G., Spina, M., Arcaini, L., Steffanoni, S., Dalu, D., Cattaneo, C., Facchetti, F., Tucci, A., Rossi, G., Re, A.

Volltext

Phase 1 trial of EO2463 peptide‐based immunotherapy as monotherapy and in combination with lenalidomide and rituximab in indolent non‐Hodgkin lymphoma; EONHL1‐20/SIDNEY von Pinto, A. A., Bosch, F., Bisneto, J. C. Villasboas, Sanz, R. García, Garcia, C. Grande, Smith, S. D., Wallace, D. S., Arcaini, L., Merryman, R., Marolleau, J., Filippi, R., Chêne, L., Bonny, C., Fagerberg, J., Friedberg, J. W., Ansel, S., Armand, P., Zinzani, P. L.

Volltext

RITUXIMAB AND IBRUTINIB COMBINATION IS SAFE AND EFFECTIVE IN UNTREATED SPLENIC AND NODAL MARGINAL ZONE LYMPHOMAS: PLANNED SUBSET ANALYSIS OF THE IELSG47/MALIBU PHASE II STUDY von Thieblemont, C., Lamy, T., Tani, M., Krzisch, D., Reda, G., Tedeschi, A., Usai, S. V., Guarini, A., Bijou, F., Stathis, A., Anastasia, A., Devizzi, L., Luminari, S., Arcaini, L., Casasnovas, O., Gressin, R., André, M., Houot, R., Bonomini, L., Zucca, E., Conconi, A.

Volltext

CART‐SIE REAL LIFE STUDY: PRIMARY MEDIASTINAL B‐CELL LYMPHOMA (PMBCL) HAVE A SUPERIOR OUTCOME COMPARED TO LARGE B‐CELL LYMPHOMA (LBCL) TREATED WITH AXICABTAGENE CILOLEUCEL von Chiappella, A., Dodero, A., Guidetti, A., Ljevar, S., Pennisi, M., Casadei, B., Galli, E., Di Rocco, A., Cutini, I., Barbui, A. M., Bramanti, S., Musso, M., Tisi, M. C., Carrabba, M. G, Martino, M., Farina, M., Botto, B., Grillo, G., Ladetto, M., Olivieri, J., Arcaini, L., Bermema, A., Miceli, R., Chiusolo, P., Zinzani, P. L., Corradini, P.

Volltext